Systemic Amyloidosis Recognition, Prognosis, and Therapy: A Systematic Review

Medicine & Life Sciences

• Amyloidosis 100%
• Immunoglobulin Light-chain Amyloidosis 80%
• Psychology Recognition 78%
• Amyloid 70%
• Amyloidosis, Hereditary, Transthyretin-Related 69%
• Systematic Reviews 66%
• Paresthesia 34%
• Nephrotic Syndrome 33%
• Peripheral Nervous System Diseases 31%
• Heart Failure 21%
• Librarians 21%
• Monoclonal Gammopathy of Undetermined Significance 21%
• Prealbumin 18%
• Bortezomib 18%
• Hepatomegaly 17%
• Drug Therapy 17%
• European Union 17%
• Hypesthesia 16%
• United States Food and Drug Administration 14%
• Therapeutics 14%
• Incidence 14%
• Rare Diseases 14%
• Counseling 12%
• Publications 12%
• Decision Making 12%
• Nervous System 12%
• Heart Diseases 12%
• Language 11%
• Datasets 11%
• Differential Diagnosis 11%
• Stem Cells 10%
• Cohort Studies 10%
• Randomized Controlled Trials 10%
• Quality of Life 9%
• Transplants 9%
• Phenotype 8%
• Survival 8%
• Kidney 8%
• Liver 7%